KTMED Inc. is commercializing a breakthrough in non-invasive technology for the measurement of patient parameters, such as SPO2, ETCO2, ECG, NIBP etc.
The Company is developing innovative devices for the measurement of reliable pulse oximetry (non-invasive oxygen saturation or “SpO2”) under low perfusion(poor blood flow) and signal interference(patient motion) conditions.
The Company was founded in 2000, but the technicians have specialized career in this filed over 20 years. Main target markets for the Company’s products range widely from critical care segments in hospital to a large spectrum of point-of-care testing sites in hospital, physician clinic, extended care, emergency and public health setting. KTMED offers market-leading solutions in the area of patient monitor system.